• Data
  • Studio
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Governance
    • Events
    • Newsroom
    • Careers
Contact Us

Sign In

  • Data
  • Studio
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Governance
    • Events
    • Newsroom
    • Careers
Truveta and Mathematica partner to advance public health and health equity with real-world data

Truveta and Mathematica partner to advance public health and health equity with real-world data

by Truveta Staff | Sep 21, 2023 | News

Truveta, a leading EHR data and analytics company, and Mathematica, a policy research and data analytics consultancy, today announced a partnership to advance medical research in the areas of public health surveillance, health equity, and maternal health. By engaging...
Truveta collaboration with Harvard University researchers published in JAMA Network Open

Truveta collaboration with Harvard University researchers published in JAMA Network Open

by Truveta Research | May 11, 2023 | News, Research, Research Insights

Today Truveta announced a new research letter published in JAMA Network Open using de-identified patient data from Truveta Studio. Published in collaboration with Anupam B. Jena, MD, PhD and Christopher M Worsham, MD, MPH from Harvard University, the new research...
How better medical device data can create better patient outcomes

How better medical device data can create better patient outcomes

by Truveta Staff | May 5, 2023 | Technology

Medical device companies face a unique challenge when they want to study their product performance post-launch – a significant lack of detailed data on use of their device in clinical practice and the related outcomes. Understanding clinical outcomes or adverse events...
ISPOR 2023: Presenting Truveta Research’s recent type 2 diabetes findings

ISPOR 2023: Presenting Truveta Research’s recent type 2 diabetes findings

by Truveta Staff | May 4, 2023 | News

This post is authored by Tricia Rodriguez, senior applied scientist, Truveta Research. The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is gearing up for a fantastic event, slated for May 7-10, 2023, in Boston. As an applied scientist with...
How does approval of a new Alzheimer’s drug impact genetic testing?

How does approval of a new Alzheimer’s drug impact genetic testing?

by Truveta Research | Apr 21, 2023 | Research, Research Insights

The National Institute of Health estimates that more than six million Americans over the age of 65 suffer from Alzheimer’s disease, with many more under the age of 65 also having the disease (National Institute on Aging, 2021). It is currently ranked as the seventh...
« Older Entries

Recent posts

  • Advancing epilepsy research: Insights from Truveta’s epilepsy data
  • Truveta and Mathematica partner to advance public health and health equity with real-world data
  • Medical Components, Inc. and Truveta: Using real-world data to improve patient care


Stay up-to-date

Ready to join us on our mission of Saving Lives with Data?

Get started
  • Follow
  • Follow

Truveta Data

Truveta Studio

Research

Resources

Blog

Leadership

Governance

Newsroom

Careers

Contact us

Privacy Notice

© Truveta 2023

Interested in learning more?

Reach out and we’ll schedule a demo.